Immunobiology and Application of Toll-like Receptor 4 Agonists to Augment Host Resistance to Infection

Infectious diseases remain a threat to critically ill patients, particularly with the rise of antibiotic-resistant bacteria. Septic shock carries a mortality of up to ~40% with no compelling evidence of promising therapy to reduce morbidity or mortality. Septic shock survivors are also prone to noso...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmacol Res
Autors principals: Hernandez, Antonio, Patil, Naeem K., Stothers, Cody L., Luan, Liming, McBride, Margaret A., Owen, Allison M., Burelbach, Katherine R., Williams, David L., Sherwood, Edward R., Bohannon, Julia K.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884699/
https://ncbi.nlm.nih.gov/pubmed/31689522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2019.104502
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars